Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

Med Mycol Case Rep

Department of Oncology, Hospital Mãe de Deus, Rua Jose de Alencar, 286, 90880-480 Porto Alegre, Brazil.

Published: December 2017

AI Article Synopsis

  • Probiotics are often used alongside antibiotics to help treat diarrhea associated with antibiotic use.
  • A 73-year-old patient undergoing chemotherapy developed a fungal infection (fungemia) from a central venous catheter while being treated with a specific probiotic for antibiotic-associated colitis.
  • The fungal infection was resolved after stopping the probiotic, and there was no need for replacing the central venous catheter.

Article Abstract

Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by . We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed var. fungemia in a central venous catheter during treatment of antibiotic-associated pseudomembranous colitis with the probiotic var. . Fungemia was resolved after interruption of probiotic administration without the need to replace the central venous line.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537395PMC
http://dx.doi.org/10.1016/j.mmcr.2017.07.007DOI Listing

Publication Analysis

Top Keywords

treatment antibiotic-associated
8
var fungemia
8
central venous
8
saccharomyces cerevisiae
4
cerevisiae var
4
var boulardii
4
boulardii fungemia
4
fungemia probiotic
4
probiotic treatment
4
treatment probiotics
4

Similar Publications

Infections and Factors Associated with Recurrence.

Infect Dis Clin Microbiol

December 2024

Department of Medical Microbiology, Giresun University School of Medicine, Giresun, Türkiye.

Objective: is one of the leading causes of antibiotic-associated diarrhea. Recurrent infection (rCDI) is significant because of prolonged hospital stays, morbidity, and additional costs. Our study aimed to examine the characteristics of infections and investigate factors associated with recurrence.

View Article and Find Full Text PDF

Clostridioides difficile is the leading cause of healthcare- and antibiotic-associated diarrhea. Surface layer protein A (SlpA), an essential component of the bacterium's outermost layer, contributes to colonization and inflammation. The peroxisome proliferator-activated receptor gamma (PPAR-γ) has been demonstrated to improve intestinal integrity and prevent inflammation in host cells.

View Article and Find Full Text PDF

Background: The most severe complications of antibiotic use are clostridial infection (CDI) and pseudomembranous colitis (PMC). There is a need for further study of these conditions and identification of their triggers.

Aim: To identify risk factors for severe forms of antibiotic-associated diarrhea caused by .

View Article and Find Full Text PDF

Background: Exposure of critically ill patients to antibiotics lead to intestinal dysbiosis, which often manifests as antibiotic-associated diarrhoea. Faecal microbiota transplantation restores gut microbiota and may lead to faster resolution of diarrhoea.

Methods: Into this prospective, multi-centre, randomized controlled trial we will enrol 36 critically ill patients with antibiotic-associated diarrhoea.

View Article and Find Full Text PDF

Clostridioides (Clostridium) difficile (C. difficile) infection (CDI), often severe when producing toxin A, toxin B, and CDT, can cause life-threatening fulminant infections, especially in vulnerable patients. This case report discusses a 39-year-old woman with no medical history who developed severe CDI after antibiotic treatment, leading to fatal hypovolemic shock.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!